NCT06948136View on ClinicalTrials.gov

Acute Effects of THC in Older Adult

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 6, 2025

Primary Completion Date

November 1, 2027

Study Completion Date

November 1, 2027

Conditions
Age-related Cognitive Decline
Interventions
DRUG

Delta-9-THC Low Dose

Active Delta-9-THC administered intravenously over 20 minutes.

DRUG

Placebo

Small amount of sterile ethanol (1-2 mLs), with no THC, administered intravenously over 20 minutes.

DRUG

Delta-9-THC Medium Dose

Active Delta-9-THC administered intravenously over 20 minutes

Trial Locations (1)

06516

RECRUITING

VA Connecticut Healthcare System, West Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER